Judy Kempf

Elevations in Markers of Liver Injury and Risk of Type 2 Diabetes

Anthony J. Hanley, Ken Williams, Andreas Festa et al. · Diabetes · 2004 · 384 citations · Full text

Medicine, Endocrinology, Diabetology +16

Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease

Dominique P. Germain, Joel Charrow, Robert J. Desnick et al. · Journal of Medical Genetics · 2015 · 364 citations · Full text

Medicine, Biochemistry, Clinical Sciences +10

Phenotypic characteristics of the p.Asn215Ser (p.N215S) <i>G<scp>LA</scp></i> mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study

Dominique P. Germain, Eva Brand, Alessandro P. Burlina et al. · Molecular Genetics & Genomic Medicine · 2018 · 110 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy

Marianne Ulcickas Yood, Bruce D. McCarthy, Judy Kempf et al. · American Heart Journal · 2006 · 43 citations

Public Health, Chronic Disease Prevention, Clinical Epidemiology +13

Health Resource Utilization and Direct Costs Associated with Angina for Patients with Coronary Artery Disease in a US Managed Care Setting.

Judy Kempf, Erin Buysman, Diana Brixner · PubMed · 2011 · 24 citations

Public Affairs, Cardiology, Internal Medicine +17